Organigram (OGI) Scheduled to Post Earnings on Tuesday

Organigram (TSE:OGIGet Free Report) is set to announce its earnings results before the market opens on Tuesday, August 13th. Analysts expect the company to announce earnings of C($0.07) per share for the quarter.

Organigram (TSE:OGIGet Free Report) last posted its quarterly earnings results on Tuesday, May 14th. The company reported C($0.16) earnings per share for the quarter, missing the consensus estimate of C($0.08) by C($0.08). Organigram had a negative return on equity of 54.53% and a negative net margin of 153.80%. The company had revenue of C$37.63 million for the quarter, compared to analyst estimates of C$38.20 million.

Organigram Stock Up 2.4 %

OGI opened at C$2.10 on Wednesday. Organigram has a 1-year low of C$1.35 and a 1-year high of C$3.95. The stock’s fifty day simple moving average is C$2.21 and its 200 day simple moving average is C$2.53. The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.55. The stock has a market cap of C$216.30 million, a PE ratio of -0.84, a price-to-earnings-growth ratio of 0.42 and a beta of 1.13.

Insider Transactions at Organigram

In other Organigram news, Senior Officer Paolo De Luca sold 11,899 shares of the firm’s stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of C$2.61, for a total value of C$31,056.39. 27.16% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the company. Jefferies Financial Group reduced their target price on Organigram from C$4.40 to C$4.35 in a report on Friday, May 17th. Canaccord Genuity Group reduced their target price on Organigram from C$3.75 to C$3.25 and set a “speculative buy” rating on the stock in a report on Wednesday, May 15th.

Check Out Our Latest Stock Analysis on OGI

About Organigram

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Featured Articles

Earnings History for Organigram (TSE:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.